Diego Eidy Chiba

595 total citations
11 papers, 438 citations indexed

About

Diego Eidy Chiba is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Diego Eidy Chiba has authored 11 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Diego Eidy Chiba's work include Aldose Reductase and Taurine (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and HIV/AIDS drug development and treatment (2 papers). Diego Eidy Chiba is often cited by papers focused on Aldose Reductase and Taurine (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and HIV/AIDS drug development and treatment (2 papers). Diego Eidy Chiba collaborates with scholars based in Brazil and United Kingdom. Diego Eidy Chiba's co-authors include Jean Leandro dos Santos, Chung Man Chin, Guilherme Fernandes, Daniela Hartmann Jornada, Aline Renata Pavan, Juliana Romano Lopes, Cauê Benito Scarim, Maria Elisa Lopes Pires, Iracilda Zeppone Carlos and Sisi Marcondes and has published in prestigious journals such as Molecules, Nutrients and European Journal of Medicinal Chemistry.

In The Last Decade

Diego Eidy Chiba

11 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diego Eidy Chiba Brazil 5 213 69 58 46 41 11 438
Daniela Hartmann Jornada Brazil 4 149 0.7× 151 2.2× 22 0.4× 44 1.0× 41 1.0× 6 441
Yali Zhang China 11 243 1.1× 70 1.0× 11 0.2× 107 2.3× 10 0.2× 22 493
Gaurav Parashar India 14 379 1.8× 55 0.8× 14 0.2× 45 1.0× 9 0.2× 26 597
Sonam Mittal India 14 406 1.9× 53 0.8× 15 0.3× 62 1.3× 11 0.3× 28 701
Huaqing Cui China 17 313 1.5× 162 2.3× 65 1.1× 11 0.2× 8 0.2× 30 582
Jessica L. Davis Ireland 7 174 0.8× 107 1.6× 14 0.2× 63 1.4× 7 0.2× 11 428
Mayilaadumveettil Nishana India 8 489 2.3× 78 1.1× 15 0.3× 29 0.6× 10 0.2× 12 764
Hongfei Chen China 14 210 1.0× 135 2.0× 33 0.6× 15 0.3× 8 0.2× 37 429
Somsubhra Thakur Choudhury India 10 145 0.7× 38 0.6× 8 0.1× 104 2.3× 26 0.6× 12 486
Taha F. S. Ali Egypt 19 286 1.3× 391 5.7× 53 0.9× 10 0.2× 53 1.3× 57 859

Countries citing papers authored by Diego Eidy Chiba

Since Specialization
Citations

This map shows the geographic impact of Diego Eidy Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Eidy Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Eidy Chiba more than expected).

Fields of papers citing papers by Diego Eidy Chiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Eidy Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Eidy Chiba. The network helps show where Diego Eidy Chiba may publish in the future.

Co-authorship network of co-authors of Diego Eidy Chiba

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Eidy Chiba. A scholar is included among the top collaborators of Diego Eidy Chiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Eidy Chiba. Diego Eidy Chiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chiba, Diego Eidy, et al.. (2025). Isoindoline-1,3-dione Derivatives as Prototypes for Anticonvulsant Drug Discovery. Medicinal Chemistry. 21(9). 1000–1007. 1 indexed citations
2.
Chiba, Diego Eidy, Guilherme Fernandes, Jean Leandro dos Santos, & Cauê Benito Scarim. (2024). Exploring the latest breakthroughs in rhodesain inhibitors for African trypanosomiasis. Medicinal Chemistry Research. 33(3). 354–369. 1 indexed citations
3.
Jornada, Daniela Hartmann, Diego Eidy Chiba, Marcus Alexandre Mendes Luz, et al.. (2024). Synergistic Enhancement of 5-Fluorouracil Chemotherapeutic Efficacy by Taurine in Colon Cancer Rat Model. Nutrients. 16(18). 3047–3047. 2 indexed citations
4.
Lopes, Juliana Romano, Diego Eidy Chiba, & Jean Leandro dos Santos. (2021). HIV latency reversal agents: A potential path for functional cure?. European Journal of Medicinal Chemistry. 213. 113213–113213. 11 indexed citations
5.
Scarim, Cauê Benito, et al.. (2021). Insight into Recent Drug Discoveries against Trypanosomatids andPlasmodium spp Parasites: New Metal-based Compounds. Current Medicinal Chemistry. 29(13). 2334–2381. 1 indexed citations
6.
Chin, Chung Man, et al.. (2021). The preventive effect of Taurine in early stage of colon chemical carcinogenesis. International Journal of Complementary & Alternative Medicine. 14(16). 242–244. 1 indexed citations
7.
Pires, Maria Elisa Lopes, Diego Eidy Chiba, Iracilda Zeppone Carlos, et al.. (2019). Antiplatelet activity and TNF-α release inhibition of phthalimide derivatives useful to treat sickle cell anemia. Medicinal Chemistry Research. 28(8). 1264–1271. 5 indexed citations
8.
Fernandes, Guilherme, et al.. (2017). Epigenetic Regulatory Mechanisms Induced by Resveratrol. Nutrients. 9(11). 1201–1201. 111 indexed citations
9.
Pavan, Aline Renata, Daniela Hartmann Jornada, Diego Eidy Chiba, et al.. (2016). Unraveling the Anticancer Effect of Curcumin and Resveratrol. Nutrients. 8(11). 628–628. 101 indexed citations
10.
Jornada, Daniela Hartmann, et al.. (2015). The Prodrug Approach: A Successful Tool for Improving Drug Solubility. Molecules. 21(1). 42–42. 203 indexed citations
11.
Chin, Chung Man, et al.. (2014). Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs. Current Medicinal Chemistry. 21(23). 2599–2609. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Hartmann Jornada Breakdown of academic impact, for papers by Yali Zhang Breakdown of academic impact, for papers by Gaurav Parashar Breakdown of academic impact, for papers by Sonam Mittal Breakdown of academic impact, for papers by Huaqing Cui Breakdown of academic impact, for papers by Jessica L. Davis Breakdown of academic impact, for papers by Mayilaadumveettil Nishana Breakdown of academic impact, for papers by Hongfei Chen Breakdown of academic impact, for papers by Somsubhra Thakur Choudhury Breakdown of academic impact, for papers by Taha F. S. Ali
Rankless by CCL
2026